Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Eli Lilly to target cancer drug developers for deals

The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 18, 2018. REUTERS/Brendan McDermid/File Photo

(Reuters) - Eli Lilly and Co will target cancer drug developers for deals, Chief Executive Officer Dave Ricks said on a post-earnings conference call on Wednesday.

"Probably because of the number of opportunities, you will see us active in oncology - that's where a lot of early stage biotech is," Ricks said.

(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.